Chemical Structure (F205834f 7a27 4968 9605 90a2c53ce7e9 01)
Losartan Potassium Tablet
Product Images NDC 72162-2508
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 72162-2508). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (F205834f 7a27 4968 9605 90a2c53ce7e9 02)
This text provides information about a study comparing the effectiveness of Atenolol and Losartan potassium in treating patients based on the primary endpoint. The adjusted risk reduction between the two medications is reported as 13% with a p-value of 0.021. The timeline of the study is displayed in months from 0 to 66.*
Figure 2 (F205834f 7a27 4968 9605 90a2c53ce7e9 03)
This text appears to provide information about two medications, Atenolol and Losartan potassium, possibly related to the adjusted risk reduction percentage. It also mentions the percentage of patients with fatal or non-fatal strokes over a study period of up to 66 months. The adjusted risk reduction was reported to be 25% with a significance level of p=0.001. This data may be part of a clinical study or trial evaluating the effectiveness of these medications in reducing the risk of stroke.*
Figure 3 (F205834f 7a27 4968 9605 90a2c53ce7e9 04)
Figure 4 (F205834f 7a27 4968 9605 90a2c53ce7e9 05)
This text provides information on a clinical trial comparing the effectiveness of Losartan Potassium versus Placebo in reducing risk for an event in patients. The results show a risk reduction of 16.1% with a statistical significance level of p=0.022. Additionally, out of the total patients, 9% experienced the event.*
Image (F205834f 7a27 4968 9605 90a2c53ce7e9 06)
UWNICHEM PHARMACEUTICALS (USA), INC.*
Company Logo (F205834f 7a27 4968 9605 90a2c53ce7e9 07)
Label (Lbl721622508)
The text contains information about a medication called Losartan Potassium, with a dosage of 100 mg. It includes instructions for storage and dispensing by pharmacists. The medication is in tablet form and should be kept at a temperature between 20° to 25°C. The package insert QR code provides dosage and patient information. The medication is repackaged by Bryant Ranch Prepack, Inc. and manufactured by Unichem Laboratories.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
